Evotec is a global life science company focused on advancing highly effective medicines through integrated drug discovery, preclinical development, and development-stage manufacturing solutions.

We partner with pharmaceutical companies, biotechnology companies, academic institutions, foundations, and healthcare organizations to help accelerate innovation across a wide range of therapeutic areas and technology platforms. Our work spans early discovery through preclinical development, IND-enabling support, clinical supply, and biologics manufacturing.

By combining deep scientific expertise, industrialized discovery platforms, advanced data-driven technologies, and flexible partnership models, Evotec helps organizations move promising ideas toward meaningful therapeutic outcomes.

Core Capabilities

Evotec offers integrated drug discovery and development capabilities designed to support programs from target identification and validation through hit discovery, lead optimization, and preclinical development. Our teams bring together expertise in assay development, high-throughput screening, medicinal chemistry, molecular design, structural biology, protein sciences, in vitro biology, in vivo pharmacology, ADME/DMPK, safety assessment, translational biology, and compound management.

For programs progressing toward IND and clinical development, Evotec provides development and manufacturing support across API process development, API manufacturing, drug product development, analytical development, QC testing, stability studies, formulation, bioanalysis, pharmacokinetics, pharmacometrics, regulatory support, and clinical development support.

Through Just – Evotec Biologics, we provide biologics discovery, development, and manufacturing services for antibodies, next-generation biologics, and biosimilars. Our biologics capabilities support programs from antibody discovery and cell line development through process development, analytical development, clinical manufacturing, commercial manufacturing, and advanced continuous manufacturing approaches.

Evotec also offers one of the industry’s leading iPSC-based drug discovery platforms. Our iPSC capabilities support human-relevant disease modeling, high-throughput screening, translational research, and safety assessment, helping partners better understand complex disease biology and identify promising therapeutic opportunities.

Therapeutic Areas

Evotec works across a broad range of therapeutic areas, including oncology, immunology, neuroscience, cardiovascular disease, metabolic disease, infectious disease, respiratory disease, rare diseases, cell therapy, and regenerative medicine.

Our integrated approach allows us to connect biology, chemistry, translational science, development, and manufacturing expertise around the specific needs of each program.

Best Fit Projects

Evotec is well suited for organizations seeking an integrated scientific partner for complex discovery and development programs. We support projects involving target identification, target validation, hit discovery, hit-to-lead, lead optimization, medicinal chemistry, ADME/DMPK, toxicology screening, IND-enabling development, biomarker strategy, translational biology, iPSC-based disease modeling, biologics discovery, antibody development, bispecific and multispecific development, biosimilar development, clinical manufacturing, and commercial biologics manufacturing.

Why Work With Evotec

Evotec is built to help partners move efficiently from scientific idea to therapeutic progress. Our strength lies in connecting capabilities that are often separated across multiple vendors, including discovery biology, chemistry, translational science, safety assessment, development, and manufacturing.

For partners advancing programs from early discovery toward IND, clinical supply, or biologics manufacturing, Evotec offers the scientific depth, operational scale, and integrated infrastructure needed to reduce handoffs, maintain program continuity, and support better decision-making throughout development.

Company Snapshot

Evotec is a global CRO, CDMO, and integrated drug discovery partner headquartered in Hamburg, Germany, with major operations across Europe and the United States. We support biotechnology companies, pharmaceutical companies, academic spinouts, venture-backed programs, foundations, and healthcare organizations seeking integrated scientific execution across discovery, preclinical development, IND-enabling work, ADME/DMPK, toxicology, biologics development, iPSC platforms, translational medicine, and manufacturing.